Skip to content

Allarity Therapeutics, Inc.

ALLR· NasdaqCore metricsCIK 1860657

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.68%
Market cap
$14.70M
16M shares
Filings
405
$5.00K
Q3 2026
-$6.20M
Q3 2026N/M FY25 yoy
-$5.51M
Q3 2026N/M FY25 yoy
-$10.00M
Q3 2026derivedN/M FY25 yoy
-$0.11
Q2 2024N/M FY23 yoy
$14.09M
Q3 2026−24.8% FY25 yoy
$14.70M
—
42.0×
—
-90.14%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.918824.69%$0.3012past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$320.00KFY 2025
$320.00K0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$320,000reported
FY 20242024-12-31$0reported

Capital returns

Dividends and buybacks · FY2024 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$3.19M$3.19M—15.82M sh−7.0%—
FY2024—$0.00$0.00—17.01M sh+613.0%—

Pharmaceutical preparations

Allarity Therapeutics, Inc. is the 233rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Allarity Therapeutics, Inc. · CIK 1860657 · Engraved from SEC EDGAR